Assuntos
Surtos de Doenças , Islamismo , Esportes , Viagem , Vacinas Virais/administração & dosagem , Vacinas Virais/provisão & distribuição , Febre Amarela/epidemiologia , Febre Amarela/prevenção & controle , África Ocidental/epidemiologia , China/epidemiologia , Surtos de Doenças/prevenção & controle , Saúde Global , Humanos , Oriente Médio , Febre Amarela/transmissãoRESUMO
OBJECTIVES: The purpose of our study was to assess COVID-19 vaccine acceptance among health care workers (HCWs) in the Kingdom of Saudi Arabia (KSA) and identify: 1) vaccine acceptance barriers; 2) demographic differences; and 3) the most trusted COVID-19 sources of information. METHODS: Between October and December 2020, all registered HCWs in the KSA were emailed a survey questionnaire, using Qualtrics® and Google Forms®, evaluating their acceptance of a COVID-19 vaccine. RESULTS: Of the 23,582 participants surveyed, 15,299 (64.9%) said they would accept a COVID-19 vaccine. Vaccine acceptance among HCWs differed by several demographic characteristics, with males (69.7%), Christians (71.9%), and Pakistanis (81.6%) most likely to accept a COVID-19 vaccine. Of the 8,202 (35.1%) who said they would not accept a COVID-19 vaccine, the main reason reported was fear of potential side effects (58.5%). Participants reported health officials (84.6%) as the most reliable source of COVID-19 information. Additionally, participants reported the highest confidence in the KSA Ministry of Health (88.5%). CONCLUSIONS: Overall, these findings provide KSA health care authorities with the information needed to develop public health messaging campaigns for HCWs to best address COVID-19 vaccine concerns-especially as the country prepares to vaccinate its general population.
Assuntos
COVID-19 , Vacinas , Vacinas contra COVID-19 , Estudos Transversais , Pessoal de Saúde , Humanos , Masculino , SARS-CoV-2 , Arábia SauditaAssuntos
Virus da Influenza A Subtipo H5N1 , Influenza Aviária , Influenza Humana , Humanos , Virus da Influenza A Subtipo H5N1/isolamento & purificação , Influenza Humana/epidemiologia , Influenza Humana/prevenção & controle , Influenza Aviária/epidemiologia , Influenza Aviária/prevenção & controle , Animais , Aves , Aglomeração , Vigilância da População/métodosAssuntos
Eventos de Massa , Poliomielite , Humanos , Surtos de Doenças , Saúde Pública , Arábia Saudita , Islamismo , Viagem , AglomeraçãoRESUMO
AIM: To summarize the reported Middle East respiratory syndrome-coronavirus (MERS-CoV) cases, the associated clinical presentations and the outcomes. METHODS: We searched the Saudi Ministry of Health website, the World Health Organization website, and the Flutracker website. We also searched MEDLINE and PubMed for the keywords: Middle East respiratory syndrome-coronavirus, MERS-CoV in combination with pediatric, children, childhood, infancy and pregnancy from the initial discovery of the virus in 2012 to 2016. The retrieved articles were also read to further find other articles. Relevant data were placed into an excel sheet and analyzed accordingly. Descriptive analytic statistics were used in the final analysis as deemed necessary. RESULTS: From June 2012 to April 19, 2016, there were a total of 31 pediatric MERS-CoV cases. Of these cases 13 (42%) were asymptomatic and the male to female ratio was 1.7:1. The mean age of patients was 9.8 ± 5.4 years. Twenty-five (80.6%) of the cases were reported from the Kingdom of Saudi Arabia. The most common source of infection was household contact (10 of 15 with reported source) and 5 patients acquired infection within a health care facility. Using real time reverse transcriptase polymerase chain reaction of pediatric patients revealed that 9 out of 552 (1.6%) was positive in the Kingdom of Saudi Arabia. CONCLUSION: Utilizing serology for MERS-CoV infection in Jordan and Saudi Arabia did not reveal any positive patients. Thus, the number of the pediatric MERS-CoV is low; the exact reason for the low prevalence of the disease in children is not known.